Viz.ai Raises $50M in Series B round
Viz.aiâs 2019 has been marked with strong adoption of its artificial intelligence software and securing a distribution agreement with one of medtechâs biggest players. The Tel Aviv, Israel and San Francisco-based companyâs latest accomplishment is raising $50 million in a series B round.
The financing was led by Greenoaks with participation from Threshold Ventures, CRV along with existing investors GV and Kleiner Perkins.
âThis [financing] allows us to get to the next stage,â Dr. Chris Mansi, neurosurgeon, co-founder, and CEO, told MD+DI. âOur goal is to get our technology to as many patients as possible.â
The company has developed a software that connects to hospital computed tomography (CT) scanners and alerts stroke specialists within minutes that a suspected LVO stroke has been identified, sending the radiological images directly to their smartphones where they can be viewed. Viz.ai enables a physician to provide the patient with the treatment they need as quickly as possible.
This is important because stroke is a serious and time-sensitive medical condition that requires emergency care and can cause lasting brain damage, long-term disability, and death.
Adoption rates have been significant for Viz.ai, which received a nod from FDA in February of 2018.
âWeâve been on the market since June of 2018,â...
Source: MDDI - Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
More News: Brain | CT Scan | Disability | Emergency Medicine | Hospitals | Israel Health | Medical Devices | Middle East Health | Neurology | Neurosurgery | PET Scan | Stroke